Caregen

Beta

KRX Filings & Disclosures 2026

Risk Factors

• • KRW 1.89B post-tax income and capital impact from 5% USD/KRW exchange rate movement in FY2025, up from KRW 1.58B
• • Largest FX exposure in USD assets: KRW 48.19B at FY2025-end, with USD liabilities KRW 0.42B

Management Discussion & Analysis

• • 2025 revenue KRW 72.8B (-11.84% YoY, down KRW 9.78B), operating profit KRW 20.4B (-40.44%), net income KRW 20.1B (-37.80%)
• • Global medical esthetic segment sales decreased, causing revenue drop of KRW 9.7B; management cites reduced order volume from existing clients

Business Overview

• • Peptide and growth factor-based product sales to 130 countries, 97% export ratio in FY2025
• • MyoKi muscle loss prevention peptide gained FDA NDI approval in Feb 2025 after 3-month clinical trial on 80 subjects

What are the latest Caregen DART filings in 2026?

Caregen (KRX code 214370) has filed an annual report on March 16, 2026 with DART. SignalX tracks every new DART disclosure with AI-powered English summaries of business overview, risk factors, and management discussion.

When did Caregen file its most recent annual report?

Caregen filed its most recent annual report on March 16, 2026. The annual report includes audited financial statements, business overview, risk factors, and management discussion (MD&A), all available on SignalX with AI-generated English summaries and KIFRS financial data.

What is Caregen's KRX stock code?

Caregen's KRX stock code is 214370. The 6-digit stock code is the KRX standard identifier for every listed security. You can use stock code 214370 to look up all Caregen disclosures on DART, or browse them here on SignalX with AI-powered English analysis.

How often does Caregen file with DART?

Korean listed companies file an annual report once per year (typically within 90 days of fiscal year-end), a half-year report once mid-year, and quarterly reports for Q1 and Q3 — three regular periodic disclosures plus the annual. Material event reports are filed as needed when corporate events occur. SignalX monitors DART daily.

What is the difference between annual, half-year, and quarterly reports in Korea?

An annual report is a comprehensive filing with audited financials, business overview, and risk factors — analogous to the US 10-K. A half-year (interim) report covers H1 results. Quarterly reports cover Q1 or Q3 — analogous to the US 10-Q but Korea publishes only two quarterly reports per year (with the half-year report covering Q2). SignalX provides AI-generated English summaries for all three filing types for Caregen.

Where can I find Caregen financial data and KIFRS metrics?

SignalX extracts KIFRS consolidated financial data from Caregen annual reports, including revenue, gross profit, operating income, net income, total assets, stockholders' equity, EPS (basic/diluted), operating cash flow, and capital expenditure — all in KRW. Multi-year financial trends are displayed in the Financial Summary table above.